The chemical class known as C14orf135 activators encompasses a group of compounds primarily characterized by their ability to modulate the Notch signaling pathway, which is a cell communication system integral to the regulation of cell fate decisions. These activators can influence the functional dynamics of proteins associated with this pathway, including C14orf135. The mechanism of action for these activators often involves the inhibition of gamma-secretase, an enzyme responsible for cleaving and activating various substrate proteins within the Notch pathway. By altering the cleavage process, these chemicals can change the signaling cascade, thereby influencing the activity of proteins such as C14orf135 that are believed to be connected to the Notch signaling pathway.
The use of these chemicals to investigate the biology of C14orf135 relies on their capacity to modulate signaling pathways that are either directly or indirectly related to the functional expression and regulation of C14orf135. The compounds can alter the cellular milieu in which C14orf135 operates, thereby providing insight into the role and regulation of this protein. These activators are instrumental in research focused on understanding the intricate web of interactions within cellular signaling networks. By modulating the pathway, they help delineate the contributions of C14orf135 to cellular processes. This knowledge, in turn, aids in piecing together the broader biological narrative of how cells communicate, differentiate, and maintain homeostasis, with C14orf135 being a part of this complex and highly regulated system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Gamma-secretase inhibitor that prevents Notch receptor cleavage, which could activate C14orf135 by modifying downstream effects on related proteins. | ||||||
Dibenzazepine (Deshydroxy LY 411575) | 209984-56-5 | sc-207554 sc-207554A | 2 mg 5 mg | $235.00 $260.00 | 4 | |
Potent gamma-secretase inhibitor that can alter Notch receptor processing, which could activate C14orf135 through modulation of Notch signaling. | ||||||
RO-4929097 | 847925-91-1 | sc-364602 sc-364602A | 10 mg 50 mg | $439.00 $1417.00 | 1 | |
Gamma-secretase inhibitor that can modulate Notch pathway activation, which could activate C14orf135 by influencing the functional context in which it operates. | ||||||
LY411575 | 209984-57-6 | sc-364529 sc-364529A | 10 mg 50 mg | $198.00 $473.00 | 6 | |
Gamma-secretase modulator that can change Notch receptor cleavage, which could activate C14orf135 by altering Notch pathway activity. | ||||||
(S)-HDAC-42 | 935881-37-1 | sc-296364 sc-296364A | 1 mg 5 mg | $96.00 $417.00 | ||
Gamma-secretase inhibitor that can suppress Notch signaling cascade, which could activate C14orf135 by impacting related pathways. | ||||||
L-685,458 | 292632-98-5 | sc-204042 sc-204042A | 1 mg 5 mg | $337.00 $1000.00 | 4 | |
Inhibitor of gamma-secretase that could activate C14orf135 through downstream effects on the Notch signaling pathway. | ||||||
BMS-708163 | 1146699-66-2 | sc-364444 sc-364444A | 10 mg 50 mg | $480.00 $1455.00 | 1 | |
Gamma-secretase inhibitor that can modulate the Notch signaling, which could activate C14orf135 through pathway interactions. | ||||||
Compound E | 209986-17-4 | sc-221433 sc-221433A sc-221433B | 250 µg 1 mg 5 mg | $124.00 $342.00 $967.00 | 12 | |
Small molecule that inhibits Notch signaling, which could activate C14orf135 through pathway alteration. | ||||||